Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kalvista Pharmaceuticals
(KALV) Q3 2025
Earnings
KALV
Jul 10
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q3 2025
-0.99
-0.93
-0.86
-0.8
Details
Expected EPS
-0.798889
Actual EPS
-0.99
Surprise EPS
-0.19
Surprise Percent
-23.92%
Description
Kalvista Pharmaceuticals (KALV) has reported earnings of -0.99 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login